Skip to main content

PRESS RELEASES

Date Title  
Toggle Summary Bugs in the clinic
Toggle Summary Flagship Takes a Stab at Microbiome Therapy With Seres Health
We live every day with trillions of bacterial neighbors that do all sorts of mysterious things in our guts, good and bad. The broadening scientific understanding of the “ microbiome ,” powered by the modern tools of genomic analysis, has been in the news for a while.
Toggle Summary Flagship VentureLabs™ Introduces Seres Health - Early Leader in the Development of Novel Therapeutics to Treat Diseases of the Human Microbiome
CAMBRIDGE, Mass. , Nov. 21, 2013 /PRNewswire/ -- Flagship VentureLabs announced today the launch of Seres Health after two years of development in stealth mode and $10.5 million in Series A financing during that period from Flagship Ventures and other investors.  Seres Health is a clinical-stage
Toggle Summary Be warned, bacteria: We’re putting you to work
I am writing this not for you, but for the trillions of bacteria living in you and on you: Bacteria, we know your names, and we intend to dominate you. Yes, it is a daunting and complex mission. You hide in our mouths, on our skin, and deep inside our digestive tract.
Toggle Summary Medicines from microbiota

Back to top